Showing results (1-10 of 126) with videos related to
Sort By:
Pageof 13
Journal of Immunotoxicology|June 24, 2008
Immune-Mediated Diseases II Congress: summaryMichael R Shurin, Yury S SmolkinThe Journal of Clinical Investigation|November 6, 2018
Osteopontin controls immunosuppression in the tumor microenvironmentMichael R ShurinAdvances in Experimental Medicine and Biology|December 25, 2017
Targeting Myeloid-Derived Suppressor Cells in CancerWaseem Anani, Michael R ShurinThe Journal of Clinical Investigation|May 2, 2022
Cross-talk between HIF and PD-1/PD-L1 pathways in carcinogenesis and therapyMichael R Shurin, Viktor UmanskyImmunobiology|September 3, 2014
Myeloid regulatory cells in tumor spreading and metastasisAnton A Keskinov, Michael R ShurinImmunotargets and Therapy|April 30, 2024
Clinical Significance of Uncommon, Non-Clinical, and Novel AutoantibodiesMichael R Shurin, Sarah E WheelerCancer Immunology, Immunotherapy : CII|October 9, 2013
Clinical evaluation of systemic and local immune responses in cancer: time for integrationDmitriy W Gutkin, Michael R ShurinAdvances in Experimental Medicine and Biology|August 24, 2007
Immune-mediated diseases: where do we stand?Michael R Shurin, Yuri S SmolkinExpert Review of Vaccines|June 5, 2007
Optimizing dendritic cell-based immunotherapy for cancerHua Zhong, Michael R Shurin, Baohui HanPageof 13